Ahmad Hanif, PhD

Associate Professor

Organization:

West Virginia University School of Pharmacy

Department:

Pharmaceutical Sciences

Classification:

Faculty

• BSPharm, University of Jordan, 1998
• PhD, West Virginia University, 2016

1. Garofoli M, Hanif A, Sraj S, Kuhn S. Perceptions of West Virginia Teens and Adults Regarding the Risks of Over-the-Counter Pain Medications. J Pain Palliat Care Pharmacother. 2023 June;37(2):148-156.

2. M. A. Nayeem, Werner J. Geldenhuys, Ahmad Hanif. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response. Advances in Pharmacology, accepted December 2022.

3. Nayeem MA, Hanif A, Geldenhuys WJ, Agba S. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response. Pharmacol Ther. 2022 Dec;240:108213. doi: 10.1016/j.pharmthera.2022.108213. Epub 2022 May 18. PMID: 35597366.

4. Lena Maynor, Marina Gálvez-Peralta, Ashleigh Barrickman, Ahmad Hanif, Gina Baugh. Perceived stress, academic self-concept, and coping mechanisms among pharmacy students following a curricular revision. Currents in Pharmacy Teaching and Learning, February 2022.

5. Hanif A, Agba SO, Ledent C, Tilley SL, Morisseau C, Nayeem MA. Adenosine A2A receptor and vascular response: role of soluble epoxide hydrolase, adenosine A1 receptor and angiotensin-II. Mol Cell Biochem. 2021 May;476(5):1965-1978. doi: 10.1007/s11010-021-04049-w. Epub 2021 Jan 28. PMID: 33511551.

6. S. Agba, Ahmad Hanif, M. L. Edin, D. C. Zeldin & M. A. Nayeem. Cyp2j5-Gene Deletion Effects on Acetylcholine and Adenosine-Induced Relaxation in Mice: Role of Angiotensin-II and CYP-Epoxygenase Inhibitor. Front. Pharmacol., 05 February 2020 | https://doi.org/10.3389/fphar.2020.00027

7. Ahmad Hanif, M. L. Edin, D. C. Zeldin & M. A. Nayeem. Ephx2-gene deletion affects acetylcholine-induced relaxation in angiotensin-II infused mice: role of nitric oxide and CYP-epoxygenases. Mol Cell Biochem (2019) doi: 10.1007 /s11010-019-03665-x

8. Ahmad Hanif, Maan T. Khayat, Werner J. Geldenhuys, and Mohammed A. Nayeem. Adenosine Receptors and Drug Discovery in the Cardiovascular System. CHAPTER 3.

Frontiers in Cardiovascular Drug Discovery, 2018, Vol. 4, 1-49. (Bentham Science Publishers).

9. Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Ledent C, et al. Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A2A receptor and plasma oxylipins. Prostaglandins & other lipid mediators. 2017;131:83-95. Epub 2017/09/12. doi: 10.1016/j.prostaglandins.2017.09.001. PubMed PMID: 28890385; PubMed Central PMCID: PMCPMC5635996.

10. Geldenhuys WJ, Hanif A, Yun J, Nayeem MA. Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases. Molecules (Basel, Switzerland). 2017;22(6). Epub 2017/06/08. doi: 10.3390/ molecules22060917. PubMed PMID: 28587166.

11. Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Nayeem MA. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice. PLoS One. 2017;12(3):e0174137. Epub 2017/03/23. doi: 10.1371/journal.pone.0174137. PubMed PMID: 28328948.

12. Hanif, A., Edin, M. L., Zeldin, D. C., Morisseau, C., Falck, J. R., & Nayeem, M. A. (2017). Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and omega-Hydroxylases. PLoS One, 12(1).

13. Hanif, A., Edin, M. L., Zeldin, D. C., Morisseau, C., & Nayeem, M. A. (2016). Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARgamma. PLoS One, 11(9).

14. Hanif, A. M., Edin, M. L., Zeldin, D. C., Morisseau, C., & Nayeem, M. A. (2016). Deletion of Soluble Epoxide Hydrolase Enhances Coronary Reactive Hyperemia in Isolated Mouse Heart: Role of Oxylipins and PPARgamma. Am J Physiol Regul Integr Comp Physiol, 3(00237).

2022: “Teaching Scholars Program” certificate. HSC, WVU.

2022: “P1 Outstanding Teacher of the Year”, School of Pharmacy, WVU.

2022: “P2 Outstanding Teacher of the Year”, School of Pharmacy, WVU.

2021: “Academy of Excellence in Teaching and Learning” inductee. HSC, WVU

2020: “P2 Outstanding Teacher of the Year”, School of Pharmacy, WVU.

2019: “Rho Chi Society (the academic honor society in pharmacy)” inductee, School of Pharmacy, WVU.

2018: “P2 Outstanding Teacher of the Year”, School of Pharmacy, WVU.

2016: ASPET Graduate Student Travel Award at Experimental Biology 2016, San Diego, CA, USA.

2016: Completed the required WVBOP Internship Training (1,000 hours).

2014: Invited speaker for “12‐Lipoxygenase and Disease: New Insights into Regulation and Inhibition of a Critical Enzyme” symposium organized by the American Society for Pharmacology and Experimental Therapeutics (ASPET) at Experimental Biology 14, San Diego, CA, USA.

Professional teaching

PHAR 814: Biochemical Pharmacology

PHAR 824: Cardiology SBT

PHAR 833: Endocrinology SBT

PHAR 835: Autoimmune Disorders SBT

PHAR 843: Gastroenterology SBT

PHAR 844: Infections Disease SBT

PHAR 778: Travel Medicine & Global Pharmacy Practice

PHAR 779: Drugs: Bench to Market

BMS 793A: Pharmaceutical and Pharmacological Sciences Module

Teaching is my passion, and there is always room for improvement! That is why my lectures are never the same; they keep evolving to better meet my students’ aspirations. In my classroom, I adopt the three Rs mentioned in Stephen Brookfield’s The Skillful Teacher: respect, research, and respond. I encourage students to participate, think critically, and ask questions. No effort or inquiry is ever belittled; all questions are valid. Since students’ levels and intellectual capacities are not the same, I strive to find active learning techniques to enhance my teaching. I prefer simple and effective active learning techniques, such as group discussions, peer teaching, peer evaluation, and presentation. Depending on the size of the class, I implement these techniques selectively to suit the class overall as well as the students’ individual goals. My pharmacy background, teaching experience in the pharmaceutical industry setting, and my training during the graduate program in the Physiology and Pharmacology and the Basic Pharmaceutical Sciences departments are particularly fit for effective teaching of PharmD students. My research interests include enhancing student engagement in the classroom and student wellbeing and improving coping strategies with the many stressors of graduate education. My journey with teaching has been informative, enlightening, and rewarding.